Renopharm Overview
- Founded
-
2003
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Renopharm General Information
Description
Developer of drug candidates for the treatment of hypertension and epilepsy. The company's drug candidates are based on novel no-donor compounds that do not evoke pro-drug tolerance.
Contact Information
Website
www.renopharm.com
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Primary Office
- Industrial Zone
- Nazareth 16000
- Israel
Renopharm Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 01-Jan-2015 | 00000 | Completed | Out of Business | ||
| 1. Accelerator/Incubator | 16-Dec-2003 | 00000 | 00000 | Completed | Startup |
Renopharm Patents
Renopharm Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20060183912-A1 | 1,4-bis-[4-methyl-5-(2-nitrooxy)-ethyl)-thiazol-2-yl]-butane for example; forms a naturally occurring metabolite is formed when nitric oxide is released; treating for example cardiovascular diseases, inflammation, psychiatric and neurological diseases, respiratory diseases, urogenital disorders | Active | 11-Feb-2005 | 0000000000 | |
| US-20060183718-A1 | When no is released a naturally occurring metabolite is formed; treating cardiovascular diseases, inflammation, psychiatric and neurological diseases, respiratory diseases, urogenital disorders and erectile dysfunction; 4-methyl-5-(2-nitrooxy-ethyl)-2-phenyl-thiazole for example | Active | 11-Feb-2005 | 0000000000 | |
| US-20060183913-A1 | N-[4-methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-formamide for example; compound forms a naturally occurring metabolite when no is released to slow or prevent drug tolerance; treating cardiovascular diseases, inflammation, psychiatric and neurological diseases, respiratory diseases, urogenital disorders | Active | 11-Feb-2005 | 0000000000 | |
| US-7189750-B2 | Bis-[4-methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-amine for example; use to treat nitric oxide (no)-mediated diseases such as cardiovascular diseases, inflammation, tumor suppression and psychiatric and neurological diseases; natural metabolite formed when no is released, side effect reduction | Inactive | 05-May-2004 | 0000000000 | |
| EP-1753734-A1 | Nitric oxide donors and uses thereof | Inactive | 05-May-2004 | A61K31/427 |